Skip to main content

Table 1 Characteristics of patients with DRP (n = 185)

From: Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study

Patients characteristicsn (%)
Age, mean (SD)63.5 (13.7)
Sex (male)100 (54.1)
Diagnosis
Solid tumor150 (81.1)
  Breast Cancer26 (14.1)
  Colorectal cancer26 (14.1)
  Non-small cell lung cancer22 (11.9)
  Head and neck cancer21 (11.4)
  Ovarian cancer10 (5.4)
  Cancer of the pancreas8 (4.3)
  Neuroendocrine cancer8 (4.3)
  Bladder cancer5 (2.7)
  Small cell lung cancer5 (2.7)
  Cervical cancer4 (2.2)
  Oesophageal cancer4 (2.2)
  Glioma2 (1.1)
  Sarcoma2 (1.1)
  Thymus carcinoma2 (1.1)
  Anal cancer1 (0.5)
  Astrocytoma1 (0.5)
  Biliary cancer1 (0.5)
  Gastric cancer1 (0.5)
  Prostate cancer1 (0.5)
Hematologic disease35 (18.9)
  Non Hodgkin lymphoma11 (6.0)
  Multiple myeloma8 (4.3)
  Acute leukemia7 (3.9)
  Hodgkin lymphoma3 (1.6)
  Myelomonocytic leukemia2 (1.1)
  Chronic lymphocytic leukemia1 (0.5)
  Glanzmann thrombasthenia1 (0.5)
  Hairy cell leukemia1 (0.5)
  Idiopathic thrombocytopenic purpura1 (0.5)
\